Vanderbilt University Medical Center

Selected news for the hospital/health system - Vanderbilt University Medical Center, collected since 10/2017. Recent stories appear in MobiHealthNews and NBC News. This hospital/health system shares news with Infectious Disease, COVID-19, State of Tennessee, Nashville, Tennessee, State of Colorado and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
4/23/2021 Will we need COVID-19 booster shots? healio.com ... fall and will be a combination shot meant to protect against COVID-19 and seasonal influenza.C. Buddy Creech, MD, MPH, associate professor of pediatrics and director of the Vanderbilt Vaccine Research Program at Vanderbilt University Medical Center , said it is too early to tell what role booster doses of COVID-19 vaccine may have in navigating the pandemic, and what the best timing of the shots would be. Anthony ...
4/22/2021 Ascension West, Midtown gets new president, CEO tnledger.com ... Thomas Hospital, Midtown and West campuses, effective May 1.Jagasia, who has nearly 30 years of clinical and health care administration experience, is chief of staff for the adult hospital and ambulatory clinics at Vanderbilt University Medical Center . There, she has led the COVID service line as part of the pandemic response, created an innovative discharge and transitions program and developed a patient and caregiver-centered end-of-life program ...
4/16/2021 Vanderbilt Expanding Work With Undiagnosed Diseases U.S. News & World Report Home Vanderbilt Expanding Work With Undiagnosed Diseases Vanderbilt University Medical Center is launching a new program to increase the number of patients with undiagnosed diseases that it can help each year. April 16, 2021, at 4:41 a.m. Share MoreNASHVILLE, Tenn. (AP) — Vanderbilt University Medical Center announced on Thursday it is launching a new program to increase the number of patients with undiagnosed diseases that it can help each ...
4/16/2021 Vanderbilt expanding work with undiagnosed diseases tnledger.com VOL. 45 NO. 16 Friday, April 16, 2021 Vanderbilt expanding work with undiagnosed diseasesNASHVILLE (AP) — Vanderbilt University Medical Center announced on Thursday it is launching a new program to increase the number of patients with undiagnosed diseases that it can help each year.The Nashville, Tennessee, medical center already works with the National Institutes of Health's Undiagnosed Diseases Network. Now it is creating its own Vanderbilt Undiagnosed Diseases ...
4/14/2021 Spectrum Solutions Names Dr. David J. Vigerust as Chief Scientific Officer | Business Wire Business Wire ... scientific knowledge across multiple disciplines in biotechnology, medicine, and life science,” said Stephen Fanning, CEO of Spectrum Solutions.In addition to his new role at Spectrum, Dr. Vigerust additionally holds teaching positions at Vanderbilt University Medical Center in the Department of Neurological Surgery as well as the University of Maryland, Eastern Shore School of Pharmacy. Throughout his career, he has developed several novel molecular diagnostic assays for the prediction ...
4/14/2021 Spectrum Solutions Names Dr. David J. Vigerust as Chief Scientific Officer Business Wire ... scientific knowledge across multiple disciplines in biotechnology, medicine, and life science,” said Stephen Fanning, CEO of Spectrum Solutions.In addition to his new role at Spectrum, Dr. Vigerust additionally holds teaching positions at Vanderbilt University Medical Center in the Department of Neurological Surgery as well as the University of Maryland, Eastern Shore School of Pharmacy. Throughout his career, he has developed several novel molecular diagnostic assays for the prediction ...
4/12/2021 TOMORROW: Rubio, Gillibrand, Ruiz, Veterans Advocates to Announce Landmark Burn Pits Legislation to Help Veterans US Senate ... MP, U.S. Army, Board Chairman, Stronghold Freedom FoundationCindy Aman, SPC, Missouri Army National GuardGina Cancelino, Surviving spouse of Ret. GySgt Joseph Cancelino USMC, Burn Pits AdvocateDr. Robert Miller, Professor of Medicine Vanderbilt University Medical Center Kristina Keenan, Associate director, Veterans of Foreign WarsDan Brewer, Lt. Col. (Ret.), U.S. Army, former environmental officerPLACE:VFW Building (press conference will be held outside)200 Maryland Ave NERSVP ...
4/9/2021 Akili to study EndeavorRx as a COVID-19 brain fog treatment MobiHealthNews ... Novo-authorized digital therapeutic EndeavorRx, will be testing its video game ADHD treatment as a potential treatment for cognitive impairments in COVID-19 survivors.Through collaborations with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center , Akili will conduct two separate randomized, controlled clinical studies evaluating EndeavorRx’s ability to target and improve cognitive functioning in COVID-19 survivors who have exhibited a deficit in cognition.EndeavorRx (previously ...
4/9/2021 Pfizer requests FDA clearance for vaccine in kids ages 12 to 15 NBC News ... 100 percent effective in children ages 12 to 15 "Vaccinating our teenagers is the next step in seeing our way through the pandemic," said Dr. Buddy Creech, a pediatric infectious disease expert at the Vanderbilt University Medical Center in Nashville, Tennessee."By extending the age groups that can receive vaccine, we can continue our efforts to protect those that are most vulnerable: older adults as well as adults and teenagers ...
4/9/2021 Who Can Effectively Champion the Vax? rand.org Who Can Effectively Champion the Vax? commentary (MedPage Today) Nurse practitioner Lisa Flemmons and chief nursing officer Robin L. Steaban give a thumbs up after Flemmons received a COVID-19 vaccine at Vanderbilt University Medical Center in Nashville, Tennessee, December 17, 2020 Photo by George Walker IV/USA Today via Reuters by Lois M. Davis and Michael S. Pollard April 9, 2021Vaccine hesitancy—the delay by people to get ...
4/8/2021 Startup collaborates with NewYork-Presbyterian, Vanderbilt to test video game therapy for COVID 'brain fog' | FierceHealthcare FierceHealthcare ... COVID-19. Some people with COVID-19 report having brain fog for weeks or months after their respiratory symptoms pass.Boston-based Akili Interactive is collaborating with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to evaluate the company's digital therapeutic, AKL-T01, as a treatment for patients with cognitive dysfunction following COVID-19.The company develops video game-based digital therapeutics to improve cognitive function. Akili ...
4/7/2021 Health Systems to Use mHealth to Help COVID-19 Patients With ‘Brain Fog’ mHealth Intelligence ... testing an mHealth platform aimed at helping patients experiencing cognitive dysfunction following COVID-19, a side effect to the coronavirus pandemic that could affect long-term recovery.Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center are partnering with Akili Interactive on the connected health program, which will use Akili’s AKL-T01 digital therapeutic platform to combat what’s being called “brain fog.” They’ll begin ...
4/7/2021 Akili's therapeutic game will be tested as a treatment for Covid ‘brain fog’ STAT ... now plans to test if its software can help adults suffering from Covid “brain fog.”Two randomized remote studies, one conducted by Weill Cornell Medicine and NewYork-Presbyterian Hospital and the other by Vanderbilt University Medical Center , will assess whether AKL-T01, the treatment that Akili commercially markets for ADHD as EndeavorRx, can help improve cognition symptoms in Covid survivors.The new studies come at a pivotal moment for ...
4/7/2021 PureTech Founded Entity Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Potential Treatment for Patients with COVID Brain Fog Yahoo News ... dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, is pleased to note that its Founded Entity, Akili Interactive (Akili) today announced collaborations with Weill Cornell Medicine , NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to evaluate Akili digital therapeutic AKL-T01 as a treatment for patients with cognitive dysfunction following COVID-19 (also known as "COVID brain fog"). There are currently no approved treatments for cognitive ...
4/7/2021 PureTech Founded Entity Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Potential Treatment for Patients with COVID Brain Fog neuro-central.com ... dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, is pleased to note that its Founded Entity, Akili Interactive (Akili) today announced collaborations with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to evaluate Akili digital therapeutic AKL-T01 as a treatment for patients with cognitive dysfunction following COVID-19 (also known as “COVID brain fog”). There are currently no approved treatments for ...
4/7/2021 PureTech Founded Entity Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Potential Treatment for Patients with COVID Brain Fog financialbuzz.com ... dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, is pleased to note that its Founded Entity, Akili Interactive (Akili) today announced collaborations with Weill Cornell Medicine , NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to evaluate Akili digital therapeutic AKL-T01 as a treatment for patients with cognitive dysfunction following COVID-19 (also known as “COVID brain fog”). There are currently no approved treatments for ...
4/7/2021 Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Treatment for Patients with COVID Brain Fog | Business Wire Business Wire BOSTON- Akili Interactive (“Akili” or “Company"), today announced collaborations with Weill Cornell Medicine , NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to evaluate Akili digital therapeutic AKL-T01 as a treatment for patients with cognitive dysfunction following COVID-19 (also known as “COVID brain fog”). There are currently no approved treatments for cognitive impairments in COVID-19 survivors.Under each collaboration, Akili will work with research teams at ...
4/7/2021 Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Treatment for Patients with COVID Brain Fog Yahoo News AKL-T01 is the first and only digital therapeutic specifically designed to improve attention functionAkili Interactive ("Akili" or "Company"), today announced collaborations with Weill Cornell Medicine , NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to evaluate Akili digital therapeutic AKL-T01 as a treatment for patients with cognitive dysfunction following COVID-19 (also known as "COVID brain fog"). There are currently no approved treatments for cognitive impairments in COVID ...
4/7/2021 Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Treatment for Patients with COVID Brain Fog Yahoo News AKL-T01 is the first and only digital therapeutic specifically designed to improve attention functionAkili Interactive ("Akili" or "Company"), today announced collaborations with Weill Cornell Medicine , NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to evaluate Akili digital therapeutic AKL-T01 as a treatment for patients with cognitive dysfunction following COVID-19 (also known as "COVID brain fog"). There are currently no approved treatments for cognitive impairments in COVID ...
4/7/2021 Other news to note for April 7, 2021 | 07 BioWorld ... patients. The peptides can be used for delivery of therapeutic agents to inflamed tissue. Terms were not disclosed.Akili Interactive Inc. , of Boston, disclosed collaborations with Weill Cornell Medicine, New York-Presbyterian Hospital and Vanderbilt University Medical Center to evaluate digital therapeutic AKL-T01 as a treatment for patients with cognitive dysfunction following COVID-19. There are no approved treatments for cognitive impairments in COVID-19 survivors. Under each collaboration ...